Global Cardiopulmonary Bypass Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Heart–Lung Machines, Oxygenators, Autotransfusion Systems, and OthersBy Product Type;
Single Roller Pump and Double Roller PumpBy Application;
Cardiovascular, Respiratory, Hemodialysis, and OthersBy End Users;
Hospitals and Ambulatory Surgical CentersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Cardiopulmonary Bypass Equipment Market Overview
Cardiopulmonary Bypass Equipment Market (USD Million)
Cardiopulmonary Bypass Equipment Market was valued at USD 2,033.33 million in the year 2024. The size of this market is expected to increase to USD 2,946.09 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.4%.
Global Cardiopulmonary Bypass Equipment Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 5.4 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 5.4 % |
Market Size (2024) | USD 2,033.33 Million |
Market Size (2031) | USD 2,946.09 Million |
Market Concentration | Medium |
Report Pages | 371 |
Major Players
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- Braile Biomedica
- Sorin Group
- Maquet (a subsidiary of Getinge AB)
- Xenios AG
- MicroPort Scientific Corporation
- SynCardia Systems, LLC
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Cardiopulmonary Bypass Equipment Market
Fragmented - Highly competitive market without dominant players
The Cardiopulmonary Bypass Equipment Market is growing steadily as the number of heart surgeries continues to rise. These systems are vital for procedures like heart transplants and bypass grafting, where blood flow must be maintained externally. More than 55% of major heart operations now depend on these devices, underlining their critical role in modern surgical care.
Innovations Enhancing Clinical Outcomes
Advances in bypass system technologies, such as improved oxygenators and compact pump designs, are significantly improving surgical safety. These innovations have contributed to a 40% increase in successful procedural outcomes. Real-time monitoring and data integration features are also making the systems more reliable and precise for use during critical interventions.
Increasing Prevalence of Cardiopulmonary Disorders
As cardiac and respiratory disorders continue to rise, the use of bypass systems in surgeries is increasing. These devices are involved in over 60% of complex surgical procedures that require temporary heart or lung support, highlighting their vital function in critical care environments.
Infrastructure and Policy Support for Adoption
Enhanced healthcare funding and a focus on upgrading surgical facilities are contributing to broader adoption. Approximately 45% of advanced care hospitals now use high-performance bypass equipment, driven by the need for precision and improved patient care standards.
Cardiopulmonary Bypass Equipment Market Recent Developments
-
In January 2024, Inspira Technologies launched a single-use disposable blood oxygenation kit for its INSPIRA ART series. Designed to also integrate with cardiopulmonary bypass devices, the kit aims to lower costs and boost hospital budget efficiency.
-
In March 2023, LivaNova secured FDA clearance for its Essenz Heart-Lung Machine (HLM), launching the Essenz Perfusion System in the U.S. This system supports data-driven perfusion and enhances patient care during cardiopulmonary bypass procedures.
Cardiopulmonary Bypass Equipment Market Segment Analysis
In this report, the Cardiopulmonary Bypass Equipment Market has been segmented by Product, Product Type, Application, End Users, and Geography.
Cardiopulmonary Bypass Equipment Market, Segmentation by Product
The Cardiopulmonary Bypass Equipment Market has been segmented by Product into Heart–Lung Machines, Oxygenators, Autotransfusion Systems, and Others.
Heart–Lung Machines
Heart–lung machines play a vital role in cardiopulmonary bypass procedures by temporarily replacing the functions of the heart and lungs during surgery. This segment leads the market, contributing approximately 35–40% of the total share. Their widespread adoption is driven by advancements in pump technology, precision control systems, and their critical importance in complex cardiac surgeries.
Oxygenators
Oxygenators are indispensable in bypass surgeries, facilitating the exchange of oxygen and carbon dioxide in the patient's blood. They hold a significant market share of around 25–30%, with membrane oxygenators increasingly preferred due to their superior performance and safety profile. Demand is rising across both adult and pediatric cardiovascular procedures.
Autotransfusion Systems
Autotransfusion systems are gaining momentum for their ability to collect, filter, and reinfuse a patient’s own blood during surgery, minimizing reliance on donor blood. This segment represents nearly 15–20% of the global market. The growing focus on reducing transfusion-related risks and post-operative complications has significantly boosted their adoption in cardiac and orthopedic surgeries.
Others
This category includes essential supplementary equipment such as cannulae, filters, reservoirs, and suction devices. While each item contributes modestly, the combined segment accounts for 10–15% of the overall market. Innovation in disposable surgical tools and accessories is enhancing procedural efficiency and improving patient outcomes, thereby supporting steady growth in this segment.
Cardiopulmonary Bypass Equipment Market, Segmentation by Product Type
The Cardiopulmonary Bypass Equipment Market has been segmented by Product Type into Single Roller Pump and Double Roller Pump.
Single Roller Pump
Single roller pumps are a preferred choice in cardiopulmonary bypass procedures due to their compact design, affordability, and operational simplicity. They currently dominate the market with an estimated 55–60% share. Their user-friendly nature and minimal maintenance needs make them ideal for standard cardiac surgeries in both developed and emerging healthcare settings.
Double Roller Pump
Double roller pumps are engineered for enhanced flow stability and reduced blood cell damage, making them suitable for high-precision surgical procedures. This segment captures about 40–45% of the global market. Despite being more expensive than single roller systems, their ability to ensure continuous, accurate perfusion is increasingly valued in advanced cardiac care units and complex operations.
Cardiopulmonary Bypass Equipment Market, Segmentation by Application
The Cardiopulmonary Bypass Equipment Market has been segmented by Application into Cardiovascular, Respiratory, Hemodialysis, and Others.
Cardiovascular
The cardiovascular application leads the cardiopulmonary bypass equipment market with a dominant 50–55% share. The rising incidence of cardiovascular diseases and the growing number of open-heart surgeries globally drive this segment. The equipment’s role in ensuring stable blood flow and oxygenation makes it indispensable in cardiac operating rooms.
Respiratory
Representing nearly 20–25% of the market, the respiratory segment is gaining traction for its use in conditions like ARDS and respiratory failure. The expanding use of ECMO systems in ICUs and emergency care has significantly elevated the relevance of bypass equipment in this field. The technology’s ability to support lung function externally enhances survival rates in critical cases.
Hemodialysis
The hemodialysis segment accounts for about 10–15% of the market and is used to support kidney function in patients undergoing complex treatments. As chronic kidney disease (CKD) cases surge worldwide, demand for efficient blood purification and volume control systems continues to grow, positioning this segment for long-term expansion.
Others
Covering specialized uses such as organ transplantation, neonatal care, and sepsis treatment, the ‘others’ segment comprises about 5–10% of the market. Although smaller in volume, ongoing innovation in bypass applications across diverse medical scenarios is creating new avenues for growth in this category.
Cardiopulmonary Bypass Equipment Market, Segmentation by End Users
The Cardiopulmonary Bypass Equipment Market has been segmented by End Users into Hospitals and Ambulatory Surgical Centers.
Hospitals
The hospital segment dominates the cardiopulmonary bypass equipment market, holding a strong 75–80% share. This leadership is driven by the presence of advanced medical infrastructure, availability of skilled cardiac surgeons, and the high frequency of complex cardiovascular surgeries. The rising global burden of heart diseases continues to boost demand within hospital settings.
Ambulatory Surgical Centers
Accounting for approximately 20–25% of the market, ambulatory surgical centers (ASCs) are emerging as a growing force in cardiac care delivery. Their appeal lies in cost efficiency, shorter patient stays, and quick recovery. Technological improvements in compact and mobile bypass systems are accelerating their use in outpatient cardiac interventions.
Cardiopulmonary Bypass Equipment Market, Segmentation by Geography
In this report, the Cardiopulmonary Bypass Equipment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Cardiopulmonary Bypass Equipment Market Share (%), by Geographical Region
North America
North America leads the cardiopulmonary bypass equipment market, capturing a substantial 35–40% share. The region benefits from a high rate of cardiac procedures, robust technological advancements, and strong support from healthcare reimbursement systems, especially in the U.S. and Canada.
Europe
Europe holds a significant market share of around 25–30%, driven by the growing burden of heart-related diseases and the region’s focus on minimally invasive cardiac procedures. Access to well-established medical facilities and favorable healthcare policies continue to drive consistent demand.
Asia Pacific
Asia Pacific accounts for 20–25% of the global market and is expected to experience rapid growth. Increasing government healthcare funding, a rise in open-heart surgeries, and expanding hospital infrastructure in countries like China and India contribute to this momentum.
Middle East and Africa
With a market share of 5–10%, the Middle East and Africa are steadily advancing in the cardiopulmonary bypass equipment space. Improvements in surgical capabilities, growth in urban medical centers, and a rising focus on cardiac care access are shaping this region’s development.
Latin America
Latin America represents approximately 5–8% of the global market. The region is seeing progress due to increasing investments in healthcare modernization, a higher prevalence of cardiovascular diseases, and the gradual integration of advanced bypass systems in medical practices.
Cardiopulmonary Bypass Equipment Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Cardiopulmonary Bypass Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunities Analysis
Drivers:
- Increasing prevalence of cardiovascular diseases
- Technological advancements
- Growing demand for minimally invasive procedures
-
Rising healthcare expenditure - Rising healthcare expenditure is a crucial driver fueling the growth of the cardiopulmonary bypass equipment market. As national and private healthcare systems allocate larger budgets to modernize infrastructure and improve surgical capabilities, there is a parallel rise in the procurement of advanced cardiopulmonary support systems. These investments are aimed at improving outcomes in complex cardiovascular procedures, including open-heart surgeries where bypass equipment plays a critical role in maintaining circulatory and respiratory function during intervention.
Increased spending has also enhanced access to specialized surgical centers and cardiac care units, particularly in emerging economies that are expanding their tertiary care capacities. This has led to greater adoption of technologically advanced, efficient, and safer bypass equipment. The growing emphasis on improving perioperative patient care and reducing procedural risks further supports the demand for reliable cardiopulmonary bypass systems, contributing to sustained market growth worldwide.
Restraints:
- High cost of equipment
- Stringent regulatory requirements
- Complications associated with bypass procedures
- Limited reimbursement policies
-
Alternatives to bypass surgery - Alternatives to bypass surgery represent a significant restraint on the cardiopulmonary bypass equipment market. The growing adoption of less invasive procedures such as percutaneous coronary interventions (PCI), angioplasty, and the use of drug-eluting stents is reducing the number of patients requiring open-heart surgery. These alternatives often offer shorter recovery times, lower risk profiles, and reduced hospital stays, making them more appealing to both patients and healthcare providers. As a result, the reliance on traditional bypass procedures—and the associated equipment—is gradually declining.
Technological innovations in interventional cardiology have further advanced the capabilities of non-surgical treatment options, allowing for complex cardiac conditions to be managed without cardiopulmonary bypass systems. The increasing preference for these minimally invasive approaches is particularly evident in developed regions with access to advanced catheter-based therapies. This shift in clinical practice patterns poses a challenge to the growth potential of cardiopulmonary bypass equipment, especially as healthcare systems seek to reduce costs and optimize resource allocation.
Opportunities:
- Development of hybrid operating rooms
- Focus on product innovation
- Collaborations and partnerships
-
Increasing awareness and education - Increasing awareness and education are opening new avenues of opportunity in the cardiopulmonary bypass equipment market. As public health campaigns and clinical outreach programs emphasize the importance of early diagnosis and intervention for cardiovascular conditions, more patients are seeking timely medical attention. This shift in behavior is leading to a rise in surgical interventions where cardiopulmonary bypass systems are essential, driving steady demand across healthcare institutions.
Educational efforts targeting both patients and healthcare professionals are also enhancing procedural acceptance and clinical outcomes. Physicians are increasingly trained in advanced cardiac surgical techniques and the optimal use of bypass equipment, improving procedural safety and reducing perioperative complications. These training initiatives are especially impactful in emerging markets, where the development of cardiac care infrastructure is accompanied by investments in workforce capabilities and technology adoption.
Patient awareness is equally critical in encouraging trust in surgical solutions. With better understanding of the safety, effectiveness, and long-term benefits of procedures involving cardiopulmonary bypass, individuals are more likely to opt for surgical treatment over less effective alternatives. This rising confidence contributes to higher utilization rates, particularly for complex surgeries where bypass support is indispensable.
Furthermore, the expansion of digital education platforms, webinars, and professional certification programs is accelerating knowledge dissemination across healthcare networks. As awareness and expertise grow, the adoption of advanced bypass systems is expected to rise, creating long-term growth prospects for manufacturers and healthcare providers alike.
Cardiopulmonary Bypass Equipment Market Competitive Landscape Analysis
Key players in Cardiopulmonary Bypass Equipment Market include:
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- Braile Biomedica
- Sorin Group
- Maquet (a subsidiary of Getinge AB)
- Xenios AG
- MicroPort Scientific Corporation
- SynCardia Systems, LLC
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Cardiopulmonary Bypass Equipment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing prevalence of cardiovascular diseases
- Technological advancements
- Growing demand for minimally invasive procedures
- Rising healthcare expenditure
- Restraints
- High cost of equipment
- Stringent regulatory requirements
- Complications associated with bypass procedures
- Limited reimbursement policies
- Alternatives to bypass surgery
- Opportunities
- Development of hybrid operating rooms
- Focus on product innovation
- Collaborations and partnerships
- Increasing awareness and education
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Cardiopulmonary Bypass Equipment Market, By Product , 2021 - 2031 (USD Million)
- Heart–Lung Machines
- Oxygenators
- Autotransfusion Systems
- Others
- Cardiopulmonary Bypass Equipment Market, By Product Type, 2021 - 2031 (USD Million)
- Single Roller Pump
- Double Roller Pump
- Cardiopulmonary Bypass Equipment Market, By Application, 2021 - 2031 (USD Million)
- Cardiovascular
- Respiratory
- Hemodialysis
- Others
- Cardiopulmonary Bypass Equipment Market, By End Users, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Cardiopulmonary Bypass Equipment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Cardiopulmonary Bypass Equipment Market, By Product , 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- Braile Biomedica
- Sorin Group
- Maquet (a subsidiary of Getinge AB)
- Xenios AG
- MicroPort Scientific Corporation
- SynCardia Systems, LLC
- Company Profiles
- Analyst Views
- Future Outlook of the Market